Latest News

Emboline completes enrolment in SAFEPASS 2 clinical trial

Emboline has completed enrolment in its SAFEPASS 2 clinical study of the Emboliner embolic protection catheter. A press release from the company, which develops...

Features

BIBA Briefings: Sapien 3 becomes first TAVI valve to be approved...

Edwards Lifesciences has received the CE mark for its Sapien 3 transcatheter aortic valve implantation (TAVI) device to be used to manage aortic stenosis...

BIBA Briefings: Longest and largest follow-up data for Watchman supports its...

Data from the CAP and CAP2 registries—which contain the longest and largest follow-up of patients—add to previous evidence that left atrial appendage closure (LAAC)...

Videos

Michael Reardon (Houston, USA) talks to BLearning Cardio about the ADAPT tissue technology (Admedus), and the increasing importance of durability as TAVI moves to younger and lower risk patients. Reardon notes that “we would like to have technology that does even better...

Events

Ehtisham Mahmud

Adrian Banning

Robert W Yeh